NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01763645,A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer,https://clinicaltrials.gov/study/NCT01763645,,COMPLETED,BCD-021-02 is a double-blind randomized clinical trial comparing efficacy of BCD-021 (INN: bevacizumab) and paclitaxel + carboplatin to Avastin and paclitaxel + carboplatin in inoperable or advanced non-squamous NSCLC patients with pharmacokinetics substudy. The purpose of the study is to demonstrate the non-inferiority of efficacy and safety of BCD-021 compared to Avastin. Also study includes pharmacokinetics assessment.,YES,Non-small Cell Lung Cancer,DRUG: Bevacizumab|DRUG: Paclitaxel|DRUG: Carboplatin,"Overall Response Rate, Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), \>=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR., Day 127|Area Under the Curve After the First Test Drug Administration, primary outcome measure for pharmacokinetics (PK) substudy, up to Day 22, after the first bevacizumab administration (time points for blood samples: 0 h 1.5 h, 3 h, 4.5 h, 6 h, 24 h, 96 h, 168 h, 336 h and 504 h)","Complete Response Rate, secondary outcome measure for efficacy evaluation, Day 127|Partial Response Rate, secondary outcome measure for efficacy evaluation, Day 127|Stabilization Rate, secondary outcome measure for efficacy evaluation, Day 127|Progression Rate, secondary outcome measure for efficacy evaluation, Day 127|Occurrence of Anti-bevacizumab Antibodies, Secondary outcome measure for immunogenicity assessment, Day 1 (before the drug administration), Day 15, 64 and 127",,Biocad,,ALL,"ADULT, OLDER_ADULT",PHASE3,353,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",BCD-021-02,2012-10,2014-11,2014-11,2013-01-09,2016-10-24,2024-01-11,"Brest Regional Clinical Dispensary, Brest, Belarus|Gomel Regional Clinical Oncology Dispensary, Gomel, Belarus|Grodno Regional Clinical Hospital, Grodno, Belarus|Vitebsk Regional Clinical Oncology Dispensary, Vitebsk, Belarus|HCG Bangalore Institute of Oncology, Bangalore, 560027, India|M.S.Ramaiah Memorial Hospital, Bangalore, 560054, India|Narayana Hrudayalaya Hospitals, Bangalore, 560099, India|Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, 163045, Russian Federation|Non-governmental Healthcare Institution ""Railway Clinical hospital on the Chelyabinsk Station of JSC Russian Railways"", Chelyabinsk, 454000, Russian Federation|State-financed Health Institution ""Chelyabinsk Region Clinical Oncology Dispansary"", Chelyabinsk, Russian Federation|State Healthcare Facility ""Kursk Regional Oncology Dispensary"", Kursk, 305035, Russian Federation|State Health Institution of Moscow ""Moscow City Oncology Hospital #62 of Moscow Board of Health"", Moscow Region, 143423, Russian Federation|Institution of Russian Academy of Medical Sciences ""Russian Cancer Research Center named after N.N. Blokhin"", Moscow, 115478, Russian Federation|Federal State Institution ""Moscow Institute of Cancer Research named after P.A. Hertsen"" Ministry of Health of Russian Federation, Moscow, 194044, Russian Federation|Murmansk Regional Oncology Dispensary, Murmansk, 183047, Russian Federation|Nizhny Novgorod Region State Budgetary Healthcare Facility ""Clinical Diagnostics Center"", Nizhny Novgorod, 603006, Russian Federation|State Healthcare Facility ""Nizhny Novgorod Regional Oncology Dispensary"", Nizhny Novgorod, Russian Federation|City Clinical Hospital №1, Novosibirsk, 630047, Russian Federation|Regional State Health Institution ""Orlov Oncology Dispansary"", Orel, 302020, Russian Federation|State Health Institution ""Region Oncology Dispansary"", Penza, 440071, Russian Federation|Perm Region Oncology Dispensary, Perm, 614066, Russian Federation|Federal Government Budgetary Institution ""Rostov Institute of Cancer Research"" of Ministry of Health of Russian Federation, Rostov-on-Don, 314019, Russian Federation|Saint Petersburg City Clinical Oncology Center, Saint Petersburg, 197022, Russian Federation|State-financed Health Institution ""Samara Region Clinical Oncology Dispansary"", Samara, 443031, Russian Federation|Oncology Dispensary 2, Sochi, 354057, Russian Federation|St. Petersburg State Medical University n.a. I. P. Pavlov, St. Petersburg, 197022, Russian Federation|St. Petersburg Research and Practice Center for Secondary Care in Oncology, St. Petersburg, 197758, Russian Federation|N.N.Petrov Oncology Research Center, St.Petersburg, 197758, Russian Federation|Military Medical Academy named after S.M. Kirov, St.Petersburg, Russian Federation|Russian scientific center of radiology and surgery technologies, St.Petersburg, Russian Federation|State-financed Health Institution ""Stavropol Region Clinical Oncology Dispansary"", Stavropol, 355047, Russian Federation|Volgograd District Oncology Dispensary №1, Volgograd, 400138, Russian Federation|Volgograd Regional Oncology Dispensary №3, Volgograd, 404130, Russian Federation|State Health Institution ""Voronezh Region Clinical Oncology Dispansary"", Voronezh, 394000, Russian Federation|Donetsk City Oncology Dispensary, Donetsk, Ukraine|Donetsk Regional Antitumor Center, Donetsk, Ukraine|Kharkiv Regional Clinical Oncology Center, Kharkiv, Ukraine|Kryvyi Rih Oncology Dispensary, Kryvyi Rih, Ukraine|Lviv State Regional Cancer Diagnostic and Treatment Center, Lviv, Ukraine|City Hospital № 2, Makiivka, Ukraine|Poltava Regional Clinical Oncology Dispensary, Poltava, Ukraine|Zakarpatskyi Clinical Oncology Dispensary, Uzhhorod, Ukraine|Vinnytsia Regional Clinical Oncology Dispensary, Vinnytsia, Ukraine|Zaporizhia Regional Clinical Oncology Dispensary, Zaporizhia, Ukraine",
